Key result
Higher baseline log10 BNP was an independent predictor of incident stroke (HR 1.96; 95% CI 1.13-3.41; P=0.017), specifically discriminating cardioembolic stroke risk.
Why the study?
Does B-type natriuretic peptide (BNP) predict incident stroke independent of coronary artery calcification in a population-based cohort without prior cardiovascular disease?
Cohort (n=3,675)
Does B-type natriuretic peptide (BNP) predict incident stroke independent of coronary artery calcification in a population-based cohort without prior cardiovascular disease?
Hazard Ratio: 1.96 (95% CI 1.13–3.41)
p-value: p=0.017
BNP is an independent predictor of presumable cardioembolic stroke, providing prognostic value beyond traditional risk factors and coronary artery calcification.
BACKGROUND AND PURPOSE: B-type natriuretric peptide (BNP) is a marker of cardiac dysfunction that is released from myocytes in response to ventricular wall stress. Previous studies suggested that BNP predicts stroke events in addition to classical risk factors. It was suggested that the BNP-associated risk results from coronary atherosclerosis or atrial fibrillation. METHODS: Three thousand six hundred and seventy five subjects from the population-based Heinz Nixdorf Recall study (45-75 years; 47.6% men) without previous stroke, coronary heart disease, myocardial infarcts, open cardiac valve surgery, pacemakers and defibrillators were followed up over 110.1 ± 23.1 months. Cox proportional hazards regressions were used to examine BNP as a stroke predictor in addition to vascular risk factors (age, gender, systolic blood pressure, low-density lipoprotein, high-density lipoprotein, diabetes, smoking), renal insufficiency, atrial fibrillation/known heart failure and coronary artery calcification. RESULTS: Eighty-nine incident strokes occurred (80 ischaemic, 9 hemorrhagic). Subjects suffering stroke had significantly higher BNP values at baseline than the remaining subjects [26.3 (Q1; Q3 = 12.9; 51.0) vs. 17.4 (9.4; 31.4); P < 0.001]. In a multivariable regression, log10 BNP was an independent stroke predictor [hazard ratio 1.96, 95% confidence interval (CI) 1.13-3.41; P = 0.017] in addition to age (1.24 per 5 years, CI 1.04-1.49; P = 0.016), systolic blood pressure (1.25 per 10 mmHg, CI 1.14-1.38; P < 0.001), smoking (2.05, CI 1.24-3.39; P = 0.005), atrial fibrillation/heart failure (2.25, CI 1.05-4.83; P = 0.037) and computed-tomography-based log10 (coronary artery calcification + 1) (1.47, CI 1.15-1.88; P = 0.002). Log10 BNP predicted stroke in men but not women, both in subjects ≤65 and >65 years. In subsequent analyses, BNP discriminated the incidence of cardioembolic stroke (P for trend = 0.001), but not stroke of macroangiopathic (P = 0.555), microangiopathic (P = 0.809) or unknown (P = 0.367) origin. CONCLUSIONS: BNP predicts presumable cardioembolic stroke independent of coronary calcification.
No takes yet. Share an insight, caveat, or question.
Kara et al. (2014) conducted a cohort in Without previous stroke or major cardiovascular disease (n=3,675). B-type natriuretic peptide (BNP) vs. Lower BNP levels was evaluated on Incident stroke (HR 1.96, 95% CI 1.13-3.41, p=0.017). Higher baseline log10 BNP was an independent predictor of incident stroke (HR 1.96; 95% CI 1.13-3.41; P=0.017), specifically discriminating cardioembolic stroke risk.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: